{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:08:42Z","timestamp":1774328922853,"version":"3.50.1"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Renal cell carcinoma (RCC), one of the most common genitourinary tumors, is induced by many factors, primarily smoking, obesity, and hypertension. As a non-acquired immunodeficiency syndrome (AIDS)-defining cancer, human immunodeficiency virus (HIV) may also play a critical role in the incidence and progression of RCC. It is evident that individuals who are infected with HIV are more likely than the general population to develop RCC. The age of RCC diagnosis among HIV-positive patients is younger than among HIV-negative individuals. However, many other characteristics remain unknown. With the increase in RCC incidence among HIV-infected patients, more research is being conducted to discover the relationship between RCC and HIV, especially with regard to HIV-induced immunodeficiency, diagnosis, and treatment. Unexpectedly, the majority of the literature suggests that there is no relationship between RCC and HIV-induced immunodeficiency. Nonetheless, differences in pathology, symptoms, or treatment in HIV-positive patients diagnosed with RCC are a focus. In this review, we summarize the association of RCC with HIV in terms of epidemiology, risk factors, diagnosis, and treatment.<\/jats:p>","DOI":"10.3389\/fonc.2022.872438","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T05:31:55Z","timestamp":1648791115000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Renal Cell Carcinoma Associated With HIV\/AIDS: A Review of the Epidemiology, Risk Factors, Diagnosis, and Treatment"],"prefix":"10.3389","volume":"12","author":[{"given":"Zhiqiang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengmeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.10.002","article-title":"International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality","volume":"67","author":"Znaor","year":"2015","journal-title":"Eur Urol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz056","article-title":"Renal Cell Carcinoma: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Updagger","volume":"30","author":"Escudier","year":"2019","journal-title":"Ann Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2011.04.002","article-title":"Epidemiology of Renal Cell Cancer","volume":"25","author":"Cho","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"B5","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.eururo.2019.02.011","article-title":"European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update","volume":"75","author":"Ljungberg","year":"2019","journal-title":"Eur Urol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajur.2016.08.006","article-title":"Metastasis in Renal Cell Carcinoma: Biology and Implications for Therapy","volume":"3","author":"Gong","year":"2016","journal-title":"Asian J Urol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.6189183","article-title":"Isolation of a T-Lymphotropic Retrovirus From a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)","volume":"220","author":"Barre-Sinoussi","year":"1983","journal-title":"Science"},{"key":"B8","unstructured":"FACT SHEET \u2013 WORLD AIDS DAY 20212021"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2001.02376.x","article-title":"The Urologist and the Patient Infected With Human Immunodeficiency Virus or With Acquired Immunodeficiency Syndrome","volume":"88","author":"Lee","year":"2001","journal-title":"BJU Int"},{"key":"B10","article-title":"Improved Survival Among HIV-Infected Patients After Initiation of Triple-Drug Antiretroviral Regimens","volume":"160","author":"Hogg","year":"1999","journal-title":"CMAJ"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jiph.2014.08.003","article-title":"Assessing the Impact of HAART on the Incidence of Defining and Non-Defining AIDS Cancers Among Patients With HIV\/AIDS: A Systematic Review","volume":"8","author":"Cobucci","year":"2015","journal-title":"J Infect Public Health"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis613","article-title":"The Rising Challenge of Non-AIDS-Defining Cancers in HIV-Infected Patients","volume":"55","author":"Deeken","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.6626","article-title":"Highly Active Antiretroviral Therapy and the Incidence of Non-AIDS-Defining Cancers in People With HIV Infection","volume":"27","author":"Powles","year":"2009","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer Statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/apc.1997.11.161","article-title":"Increased Prevalence of Renal Cell Carcinoma in Patients With HIV Infection","volume":"11","author":"Baynham","year":"1997","journal-title":"AIDS Patient Care STDS"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(02)00124-6","article-title":"AIDS and the Urologist","volume":"30","author":"Hyun","year":"2003","journal-title":"Urol Clin North Am"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of Types of Cancer Among HIV-Infected Persons Compared With the General Population in the United States, 1992-2003","volume":"148","author":"Patel","year":"2008","journal-title":"Ann Intern Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of Cancers in People With HIV\/AIDS Compared With Immunosuppressed Transplant Recipients: A Meta-Analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2018.12.008","article-title":"Systematic Review of Modifiable Risk Factors for Kidney Cancer","volume":"37","author":"Al-Bayati","year":"2019","journal-title":"Urol Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.06.042","article-title":"The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-Analysis of Incidence and Mortality Risks","volume":"70","author":"Cumberbatch","year":"2016","journal-title":"Eur Urol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20618","article-title":"Renal Cell Carcinoma in Relation to Cigarette Smoking: Meta-Analysis of 24 Studies","volume":"114","author":"Hunt","year":"2005","journal-title":"Int J Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2015.07.008","article-title":"Underuse and Underreporting of Smoking Cessation for Smokers With a New Urologic Cancer Diagnosis","volume":"33","author":"Macleod","year":"2015","journal-title":"Urol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2008.01994.x","article-title":"Evaluation of the Association of Current Cigarette Smoking and Outcome for Patients With Clear Cell Renal Cell Carcinoma","volume":"15","author":"Parker","year":"2008","journal-title":"Int J Urol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1634\/theoncologist.2012-0335","article-title":"Active Smoking may Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib","volume":"19","author":"Keizman","year":"2014","journal-title":"Oncologist"},{"key":"B25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.clgc.2018.09.006","article-title":"Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies","volume":"17","author":"Kroeger","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15129","article-title":"Alcohol Consumption, Tobacco Smoking, and Subsequent Risk of Renal Cell Carcinoma: The JPHC Study","volume":"112","author":"Minami","year":"2021","journal-title":"Cancer Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7326\/M14-0954","article-title":"Cigarette Smoking Prevalence Among Adults With HIV Compared With the General Adult Population in the United States: Cross-Sectional Surveys","volume":"162","author":"Mdodo","year":"2015","journal-title":"Ann Intern Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0153103","DOI":"10.1371\/journal.pone.0153103","article-title":"Determinants of Smoking and Quitting in HIV-Infected Individuals","volume":"11","author":"Regan","year":"2016","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit207","article-title":"Effects of Smoking on Non-AIDS-Related Morbidity in HIV-Infected Patients","volume":"57","author":"Shirley","year":"2013","journal-title":"Clin Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"JCO2018791905","DOI":"10.1200\/JCO.2018.79.1905","article-title":"Epidemiology and Risk Factors for Kidney Cancer","volume":"2018","author":"Scelo","year":"2018","journal-title":"J Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-Mass Index and Incidence of Cancer: A Systematic Review and Meta-Analysis of Prospective Observational Studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28813","article-title":"Body Mass Index and Risk of Renal Cell Cancer: A Dose-Response Meta-Analysis of Published Cohort Studies","volume":"135","author":"Wang","year":"2014","journal-title":"Int J Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-20-0457","article-title":"Renal Cell Carcinoma (RCC): Fatter Is Better? A Review on the Role of Obesity in RCC","volume":"28","author":"Turco","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27639","article-title":"Body Mass Index and Survival in Patients With Renal Cell Carcinoma: A Clinical-Based Cohort and Meta-Analysis","volume":"132","author":"Choi","year":"2013","journal-title":"Int J Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-5538.ibju.2019.0228","article-title":"Obesity: An Independent Protective Factor for Localized Renal Cell Carcinoma in a Systemic Inflammation State","volume":"46","author":"Liu","year":"2020","journal-title":"Int Braz J Urol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12115","article-title":"Impact of Body Composition in Overweight and Obese Patients With Localised Renal Cell Carcinoma","volume":"34","author":"Darbas","year":"2020","journal-title":"In Vivo"},{"key":"B37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.15586\/jkcvhl.v8i2.169","article-title":"Impact of Body Mass Index on Survival of Metastatic Renal Cancer","volume":"8","author":"Plonski","year":"2021","journal-title":"J Kidney Cancer VHL"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09540121.2021.1935438","article-title":"Factors Associated With Overweight\/Obesity in a Cohort of People Living With HIV Over 50 Years of Age","volume":"2021","author":"Mazzitelli","year":"2021","journal-title":"AIDS Care"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2020.12.020","article-title":"A Global Trend Analysis of Kidney Cancer Incidence and Mortality and Their Associations With Smoking, Alcohol Consumption, and Metabolic Syndrome","volume":"8","author":"Huang","year":"2021","journal-title":"Eur Urol Focus"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.04.130","article-title":"Risk Factors for Renal Cell Carcinoma in the VITAL Study","volume":"190","author":"Macleod","year":"2013","journal-title":"J Urol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001286","article-title":"Blood Pressure and Kidney Cancer Risk: Meta-Analysis of Prospective Studies","volume":"35","author":"Hidayat","year":"2017","journal-title":"J Hypertens"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000406","article-title":"Hypertension in People Living With HIV","volume":"12","author":"van Zoest","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2015.97","article-title":"Evidence of Increased Blood Pressure and Hypertension Risk Among People Living With HIV on Antiretroviral Therapy: A Systematic Review With Meta-Analysis","volume":"30","author":"Nduka","year":"2016","journal-title":"J Hum Hypertens"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21334","article-title":"Incidence and Risk Factors for the Occurrence of Non-AIDS-Defining Cancers Among Human Immunodeficiency Virus-Infected Individuals","volume":"104","author":"Burgi","year":"2005","journal-title":"Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3816\/CGC.2008.n.013","article-title":"Human Immunodeficiency Virus\u2013Associated Renal Cell Carcinoma: A Transatlantic Case Series","volume":"6","author":"Gaughan","year":"2008","journal-title":"Clin Genitourin Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1159\/000463869","article-title":"Genitourinary Tumors and HIV1 Infection","volume":"18","author":"Adjiman","year":"1990","journal-title":"Eur Urol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31817ae5da","article-title":"Kidney and Bladder Cancers Among People With AIDS in the United States","volume":"48","author":"Layman","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12487","article-title":"HIV and Renal Cell Carcinoma: Experience in an Australian Statewide HIV Center","volume":"12","author":"Ong","year":"2016","journal-title":"Asia Pac J Clin Oncol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13027-021-00362-7","article-title":"Human Immunodeficiency Virus-Related Renal Cell Carcinoma: A Retrospective Study of 19 Cases","volume":"16","author":"Zhang","year":"2021","journal-title":"Infect Agent Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/ng0594-85","article-title":"Mutations of the VHL Tumour Suppressor Gene in Renal Carcinoma","volume":"7","author":"Gnarra","year":"1994","journal-title":"Nat Genet"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.12.010","article-title":"Genomics of Clear-Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis","author":"Bui","year":"2022","journal-title":"Eur Urol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00043-0","article-title":"Inhibition of HIF Is Necessary for Tumor Suppression by the Von Hippel-Lindau Protein","volume":"1","author":"Kondo","year":"2002","journal-title":"Cancer Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2147\/HIV.S124911","article-title":"Abnormalities in Alternative Splicing of Angiogenesis-Related Genes and Their Role in HIV-Related Cancers","volume":"9","author":"Mthembu","year":"2017","journal-title":"HIV AIDS (Auckl)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705162104","article-title":"Von Hippel Lindau Binding Protein 1-Mediated Degradation of Integrase Affects HIV-1 Gene Expression at a Postintegration Step","volume":"104","author":"Mousnier","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-17903-2_7","article-title":"Renal Cell Carcinoma: Clinical Presentation, Staging, and Prognostic Factors","author":"Yadlapalli","year":"2015","journal-title":"Kidney Cancer: Springer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2007.06824.x","article-title":"Update on Radiological Imaging of Renal Cell Carcinoma","volume":"99","author":"Coll","year":"2007","journal-title":"BJU Int"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2015.05.020","article-title":"Imaging of Renal Cell Carcinoma","volume":"34","author":"Sankineni","year":"2016","journal-title":"Urol Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-010-9843-3","article-title":"Urinary Ultrasonography in Screening Incidental Renal Cell Carcinoma: Is It Obligatory","volume":"43","author":"Haliloglu","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.198.3.8628872","article-title":"Small (< or = 3-Cm) Renal Masses: Detection With CT Versus US and Pathologic Correlation","volume":"198","author":"Jamis-Dow","year":"1996","journal-title":"Radiology"},{"key":"B60","unstructured":"ACR Appropriateness Criteria. Post-Treatment Follow-Up and Active Surveillance of Clinically Localized Renal Cell Carcinoma2021"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-014-0109-x","article-title":"MR Imaging in the Characterization of Small Renal Masses","volume":"39","author":"Willatt","year":"2014","journal-title":"Abdom Imaging"},{"key":"B62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40644-018-0150-z","article-title":"Renal Cell Carcinoma With Venous Extension: Prediction of Inferior Vena Cava Wall Invasion by MRI","volume":"18","author":"Adams","year":"2018","journal-title":"Cancer Imaging"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00779-w","article-title":"New Developments in Existing WHO Entities and Evolving Molecular Concepts: The Genitourinary Pathology Society (GUPS) Update on Renal Neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2020.07.009","article-title":"Kidney Cancer: An Overview of Current Therapeutic Approaches","volume":"47","author":"Chowdhury","year":"2020","journal-title":"Urol Clin North Am"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(85)90285-8","article-title":"Radiation Therapy in the Treatment of Metastatic Renal Cell Carcinoma","volume":"11","author":"Onufrey","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.016","article-title":"Recent Eupdate to the ESMO Clinical Practice Guidelines on Renal Cell Carcinoma on Cabozantinib and Nivolumab for First-Line Clear Cell Renal Cancer: Renal Cell Carcinoma: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up","volume":"32","author":"Powles","year":"2021","journal-title":"Ann Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2014.12.013","article-title":"PD-1 Blockade Therapy in Renal Cell Carcinoma: Current Studies and Future Promises","volume":"41","author":"Massari","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.07.019","article-title":"Re: Nivolumab Plus Ipilimumab Versus Sunitinib in Advanced Renal-Cell Carcinoma","volume":"74","author":"Powles","year":"2018","journal-title":"Eur Urol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/dic.212528","article-title":"Immunotherapy in Renal Cell Carcinoma: Latest Evidence and Clinical Implications","volume":"7","author":"Santoni","year":"2018","journal-title":"Drugs Context"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30436-8","article-title":"Pembrolizumab Plus Axitinib Versus Sunitinib Monotherapy as First-Line Treatment of Advanced Renal Cell Carcinoma (KEYNOTE-426): Extended Follow-Up From a Randomised, Open-Label, Phase 3 Trial","volume":"21","author":"Powles","year":"2020","journal-title":"Lancet Oncol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T Cell Exhaustion by Multiple Inhibitory Receptors During Chronic Viral Infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.3.1979","article-title":"Programmed Death 1 Expression on HIV-Specific CD4+ T Cells Is Driven by Viral Replication and Associated With T Cell Dysfunction","volume":"179","author":"D\u2019Souza","year":"2007","journal-title":"J Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nature05115","article-title":"PD-1 Expression on HIV-Specific T Cells Is Associated With T-Cell Exhaustion and Disease Progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/ni1515","article-title":"Upregulation of CTLA-4 by HIV-Specific CD4+ T Cells Correlates With Disease Progression and Defines a Reversible Immune Dysfunction","volume":"8","author":"Kaufmann","year":"2007","journal-title":"Nat Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-008-0003-7","article-title":"T-Cell Exhaustion in HIV Infection","volume":"5","author":"El-Far","year":"2008","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687296","article-title":"Reversal of the CD8(+) T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081398","article-title":"Tim-3 Expression Defines a Novel Population of Dysfunctional T Cells With Highly Elevated Frequencies in Progressive HIV-1 Infection","volume":"205","author":"Jones","year":"2008","journal-title":"J Exp Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193829","article-title":"Expression of PD-1 and Tim-3 Markers of T-Cell Exhaustion Is Associated With CD4 Dynamics During the Course of Untreated and Treated HIV Infection","volume":"13","author":"Rall\u00f3n","year":"2018","journal-title":"PloS One"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402176","article-title":"The Upregulation of LAG-3 on T Cells Defines a Subpopulation With Functional Exhaustion and Correlates With Disease Progression in HIV-Infected Subjects","volume":"194","author":"Tian","year":"2015","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005349","article-title":"TIGIT Marks Exhausted T Cells, Correlates With Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection","volume":"12","author":"Chew","year":"2016","journal-title":"PloS Pathog"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl3836","article-title":"Pembrolizumab Induces HIV Latency Reversal in People Living With HIV and Cancer on Antiretroviral Therapy","volume":"14","author":"Uldrick","year":"2022","journal-title":"Sci Transl Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jamaoncol.2019.2244","article-title":"Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer\u2014A Phase 1 Study","volume":"5","author":"Uldrick","year":"2019","journal-title":"JAMA Oncol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0465","article-title":"Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study","volume":"6","author":"Gonzalez-Cao","year":"2020","journal-title":"JAMA Oncol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e2027110","DOI":"10.1001\/jamanetworkopen.2020.27110","article-title":"Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti-PD1\/PDL1 Clinical Trials","volume":"3","author":"Reuss","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J Clin Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0964","article-title":"Excess Mortality Among HIV-Infected Individuals With Cancer in the United States","volume":"26","author":"Coghill","year":"2017","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-86081-w","article-title":"Exclusion of Patients Living With HIV From Cancer Immune Checkpoint Inhibitor Trials","volume":"11","author":"Vora","year":"2021","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.6737","article-title":"Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer: A Systematic Review","volume":"5","author":"Cook","year":"2019","journal-title":"JAMA Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ajco.13320","article-title":"Immune Checkpoint Inhibitor Therapy for Cancer Patients Infected With HIV: A Systematic Review","author":"Luo","year":"2020","journal-title":"Asia Pac J Clin Oncol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23197","article-title":"Reverse Transcriptase Inhibitors Induce Cell Differentiation and Enhance the Immunogenic Phenotype in Human Renal Clear-Cell Carcinoma","volume":"122","author":"Landriscina","year":"2008","journal-title":"Int J Cancer"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/bju.14083","article-title":"Improving the Efficacy of Proteasome Inhibitors in the Treatment of Renal Cell Carcinoma by Combination With the Human Immunodeficiency Virus (HIV)-Protease Inhibitors Lopinavir or Nelfinavir","volume":"121","author":"Abt","year":"2018","journal-title":"BJU Int"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.872438\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T05:32:01Z","timestamp":1648791121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.872438\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":91,"alternative-id":["10.3389\/fonc.2022.872438"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.872438","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"article-number":"872438"}}